First Page | Document Content | |
---|---|---|
Date: 2016-10-12 15:43:04 | 1978 Non-adherence is the most important risk factor for ledipasvir/sofosbuvir HCV treatment failure in the real world. Dost Sarpel1, Isaac Wasserman2, Alyssa L. Trochtenberg2, Kian Bichoupan1, David P. Del Bello1, PonniAdd to Reading ListSource URL: static.coreapps.netDownload Document from Source WebsiteFile Size: 38,86 KBShare Document on Facebook |